background
influenzalik
ill
ili
may
caus
varieti
pathogen
clinic
observ
littl
help
recognis
myxoviru
infect
implement
appropri
prevent
measur
limit
use
molecular
tool
underestim
role
common
pathogen
object
earli
week
flu
pandem
clinic
virolog
survey
conduct
adult
paediatr
patient
ili
refer
two
french
univers
hospit
pari
tour
aim
investig
differ
pathogen
involv
ili
describ
associ
symptom
method
pandem
influenza
diagnosi
perform
real
time
rtpcr
assay
viral
aetiolog
investig
molecular
multiplex
assay
clinic
data
collect
prospect
physician
use
standard
questionnair
result
week
endonas
swab
collect
patient
overal
sampl
posit
respiratori
pathogen
also
detect
among
neg
sampl
posit
variou
respiratori
agent
singl
infect
mix
infect
preval
virus
neg
singl
infect
rhinoviru
follow
parainfluenza
virus
adenoviru
case
identifi
patient
year
none
year
differ
clinic
symptom
observ
patient
infect
pathogen
result
highlight
high
frequenc
noninfluenza
virus
involv
ili
preepidem
period
flu
alert
lack
specif
clinic
sign
associ
influenza
infect
rapid
diagnost
screen
larg
panel
respiratori
pathogen
may
critic
defin
survey
epidem
situat
provid
critic
inform
patient
manag
order
monitor
spread
influenza
alert
health
handler
sever
epidemiolog
tool
develop
franc
network
gener
practition
sentinel
work
throughout
countri
provid
realtim
clinic
data
use
evalu
region
nation
influenza
spread
criteria
use
network
defin
clinic
influenzalik
ill
ili
occurr
sudden
fever
myalgia
respiratori
sign
gener
formal
viral
diagnosi
carri
group
dobserv
de
la
gripp
grog
second
french
network
survey
emerg
spread
influenza
virus
network
base
clinic
surveil
acut
respiratori
infect
laboratori
analysi
nasal
specimen
collect
adult
children
volunt
gener
practition
pediatrician
accord
sentinel
network
criteria
french
health
author
proclaim
flu
epidem
level
reach
second
week
septemb
week
contrari
data
provid
grog
show
sporad
activ
last
week
octob
week
thu
becam
rapidli
obviou
varieti
virus
circul
commun
overestim
myxoviru
infect
stake
better
knowledg
epidem
statu
key
featur
nation
healthcar
organ
hospit
prepared
patient
manag
diseas
control
unambigu
viral
diagnosi
appear
critic
franc
data
viral
aetiolog
associ
ili
best
sporad
correl
clinic
symptom
often
lack
extens
molecular
assay
screen
respiratori
virus
avail
countrywid
routin
diagnosi
therefor
epidemiolog
pattern
respiratori
pathogen
overlap
season
poorli
known
aim
present
studi
investig
respiratori
pathogen
involv
ili
earli
week
diffus
franc
week
describ
associ
symptom
paediatr
adult
popul
studi
nonintervent
studi
addit
usual
proceedur
biolog
materi
clinic
data
obtain
standard
viral
diagnost
follow
physician
prescript
specif
sampl
modif
sampl
protocol
supplementari
question
nation
standard
questionnair
data
analys
carri
use
anonym
databas
accord
french
health
public
law
csp
art
l
protocol
requir
approv
ethic
committe
exempt
inform
consent
applic
two
academ
hospit
saintloui
hospit
sl
pari
tour
hospit
tr
influenzalik
ill
ili
defin
patient
suffer
least
one
gener
symptom
fever
asthenia
myalgia
shiver
headach
one
respiratori
symptom
cough
dyspnoea
rhiniti
pharyng
agreement
guidelin
french
institut
de
veill
sanitair
inv
government
institut
respons
surveil
alert
domain
public
health
criteria
sever
clinic
present
temperatur
despit
antipyret
cardiac
frequenc
respiratori
frequenc
respiratori
distress
systol
arteri
pressur
mmhg
alter
conscious
predispos
factor
critic
ill
children
younger
one
year
old
pregnant
women
diabet
chronic
preexist
diseas
respiratori
cardiovascular
neurolog
renal
hepat
hematolog
diseas
immunosuppress
associ
hiv
infect
organ
hematopoiet
stem
cell
transplant
receipt
chemotherapi
corticosteroid
cluster
suspect
influenza
infect
defin
least
three
possibl
case
week
close
commun
household
school
two
institut
prescript
molecular
test
recommend
patient
ili
either
sever
clinic
present
underli
risk
factor
complic
condit
improv
antivir
treatment
investig
group
suspect
case
also
recommend
week
last
week
august
last
week
octob
endonas
swab
collect
ml
univers
transport
medium
copan
diagnost
inc
murrieta
ca
adult
children
seen
emerg
room
suspect
ili
tabl
sent
sl
tr
laboratori
detect
two
microbiolog
laboratori
particip
refer
laboratori
network
detect
pandem
influenza
clinic
data
collect
time
medic
attent
report
clinician
nation
standard
questionnair
provid
inv
questionnair
includ
presenc
absenc
main
gener
respiratori
symptom
associ
ili
fever
asthenia
myalgia
shiver
headach
cough
rhiniti
pharyng
sudden
onset
total
nucleic
acid
extract
ml
univers
transport
medium
use
easymag
system
marci
letoil
franc
sl
advanc
xl
qiagen
courtaboeuf
franc
tr
accord
manufactur
instruct
elut
volum
ml
sl
ml
tr
extract
ml
intern
amplif
control
iac
contain
encephalomyocard
viru
emc
rna
transcript
ad
sampl
pandem
infect
diagnos
realtim
revers
transcriptionpcr
rtpcr
assay
real
time
pcr
system
appli
biosystem
foster
citi
ca
accord
protocol
center
diseas
control
cdc
respiratori
infect
investig
multiplex
molecular
assay
base
multiplex
ligationdepend
probeamplif
mlpa
technolog
pathofind
maastricht
netherland
allow
detect
differenti
respiratori
virus
includ
influenza
viru
infa
influenza
viru
b
infb
rhinoviru
rhv
parainfluenza
virus
human
metapneumoviru
hmpv
adenoviru
adv
respiratori
syncyti
viru
rsva
respiratori
syncyti
viru
b
rsvb
human
coronavirus
test
allow
also
detect
influenza
viru
four
bacteria
chlamydophila
pneumonia
cp
mycoplasma
pneumonia
mp
legionella
pneumophila
lp
bordetella
pertussi
bp
amplifi
mlpa
product
analyz
abi
genet
analyz
appli
biosystem
foster
citi
ca
fragment
size
analysi
perform
genemark
softwar
softgenet
llc
state
colleg
pa
test
carri
simplexa
tm
influenza
focu
diagnost
cypress
california
cdc
real
time
rtpcr
assay
neg
assay
posit
influenza
latter
assay
neg
type
perform
previous
describ
data
studi
summar
frequenc
percentag
categor
variabl
quantit
variabl
present
median
percentil
compar
variabl
accord
viral
infect
statu
fisher
test
use
cdc
refer
assay
detect
sampl
frequent
sl
sampl
tr
sampl
overal
weekli
percentag
posit
endonas
swab
remain
week
increas
significantli
p
trend
figur
rate
detect
reach
sl
week
tr
week
overal
rate
agreement
result
provid
grog
network
show
earlier
start
epidem
pari
area
nucleic
acid
extract
analyz
use
assay
figur
sixti
six
patient
test
posit
cdc
real
time
rtpcr
assay
confirm
multiplex
assay
thirteen
also
coinfect
one
two
respiratori
pathogen
multipl
infect
figur
three
neg
sampl
could
studi
multiplex
assay
contain
rtpcr
inhibitor
amplif
intern
control
two
hundr
fifteen
remain
neg
sampl
found
posit
least
one
respiratori
pathogen
figur
two
hundr
twelv
posit
non
influenza
pathogen
singl
infect
mix
infect
two
three
four
virus
three
addit
singl
infect
influenza
identifi
sl
includ
two
pandem
one
season
determin
molecular
type
data
shown
overal
patient
posit
one
non
influenza
pathogen
singl
infect
respiratori
pathogen
mix
infect
without
figur
among
neg
singl
infect
preval
virus
rhinoviru
patient
follow
parainfluenza
virus
patient
adenoviru
patient
human
coronaviru
patient
respiratori
syncyti
viru
b
patient
figur
addit
assay
identifi
three
patient
bacteri
infect
two
mycoplasma
pneumonia
one
year
old
femal
sl
one
year
old
femal
tr
one
bordetella
pertussi
one
year
old
male
sl
singl
infect
influenza
b
hmpv
chlamydophila
pneumonia
legionella
pneumophila
identifi
figur
analyz
viral
coinfect
occur
frequent
virus
carri
two
two
comparison
show
higher
proport
coinfect
adv
p
noninfluenza
respiratori
virus
present
differ
epidem
profil
compar
overal
hospit
weekli
rate
respiratori
virus
whether
alon
involv
coinfect
increas
week
consist
decreas
figur
rhv
infect
repres
nearli
half
viral
infect
signific
contribut
factor
hospit
emerg
case
associ
rapid
declin
rhv
rate
infect
less
one
two
week
gap
sl
tr
data
age
institut
children
younger
year
age
infect
least
one
respiratori
pathogen
tabl
infect
patient
significantli
younger
non
infect
patient
year
old
vs
year
old
p
figur
howev
case
identifi
patient
year
old
sl
tr
case
observ
patient
older
year
tabl
piv
infect
occur
young
patient
median
figur
consequ
piv
adv
frequent
detect
younger
popul
tr
versu
sl
respect
contrast
although
individu
rhv
infect
slightli
younger
individu
without
median
age
vs
patient
without
rhv
p
figur
influenzalik
ill
associ
rhv
frequent
sl
tr
p
final
patient
viral
multipl
infect
significantli
younger
singl
infect
median
idr
vs
rate
mix
infect
time
medic
attent
standard
clinic
questionnair
collect
patient
four
could
exploit
incomplet
review
workabl
questionnair
show
patient
includ
studi
fulfil
criteria
ili
defin
either
sever
clinic
present
underli
risk
factor
complic
suspect
cluster
group
case
overal
patient
fever
cough
tabl
classic
clinic
sign
associ
ili
asthenia
myalgia
shiver
headach
rhiniti
pharyng
less
frequent
sudden
onset
also
describ
case
patient
temperatur
age
patient
rang
zero
year
median
age
year
mean
age
year
data
shown
infect
patient
includ
singl
multipl
infect
main
symptom
also
fever
cough
compar
clinic
characterist
patient
posit
patient
posit
respiratori
pathogen
neg
patient
without
detect
respiratori
pathogen
detect
tabl
differ
three
group
except
fever
cough
pharyng
howev
latter
symptom
comparison
patient
posit
posit
respiratori
pathogen
patient
posit
without
detect
respiratori
pathogen
show
differ
except
pharyng
less
frequent
patient
posit
patient
posit
respiratori
pathogen
tabl
rhv
frequent
aetiolog
ili
also
compar
clinic
symptom
observ
patient
singl
infect
rhv
data
shown
differ
except
rhiniti
pharyng
significantli
frequent
rhv
infect
vs
p
vs
p
respect
viral
multipl
infect
includ
sampl
associ
differ
clinic
present
fever
cough
observ
patient
respect
patient
temperatur
differ
patient
singl
viral
infect
result
highlight
high
frequenc
noninfluenza
virus
involv
acut
respiratori
infect
epidem
period
flu
alert
defin
sentinel
accord
ili
definit
sudden
fever
accompani
myalgia
respiratori
sign
data
extent
previou
observ
europ
report
high
preval
rhv
infect
season
influenza
pandem
influenza
confirm
rhv
repres
frequent
aetiolog
acut
respiratori
tabl
age
patient
respiratori
sampl
posit
posit
respiratori
pathogen
neg
infect
adult
paediatr
popul
may
repres
case
show
viral
infect
influenza
rhv
may
repres
aetiolog
observ
differ
two
hospit
higher
frequenc
parainfluenza
adv
infect
tour
contrast
higher
frequenc
rhv
pari
like
explain
higher
proport
paediatr
sampl
collect
tour
howev
despit
distanc
two
institut
km
differ
two
popul
present
similar
pattern
high
frequenc
noninfluenza
virus
acut
respiratori
infect
flu
epidem
wave
declin
influenza
reach
epidem
level
two
citi
high
frequenc
rhv
seen
level
like
differ
evolut
speed
sudden
increas
decreas
sl
progress
variat
tr
institut
decreas
proport
number
rhv
diagnos
roughli
parallel
increas
influenza
diagnos
inde
exce
posit
detect
rate
rhv
drop
data
thu
consist
neg
interact
two
epidem
popul
level
previous
hypothesis
rhv
epidem
could
interfer
spread
pandem
influenza
vitro
data
support
hypothesi
report
interferon
cytokin
product
rhv
infect
cell
induc
refractori
state
viru
infect
data
includ
three
patient
whose
respiratori
sampl
could
studi
multiplex
assay
rtpcr
inhibitor
neighbour
cell
work
need
confirm
vitro
vivo
neg
interact
viral
interfer
realli
translat
popul
level
analysi
rhinoviru
influenza
epidem
previou
year
also
help
determin
similar
interfer
observ
season
influenza
elabor
model
predict
spread
influenza
accord
respiratori
virus
circul
systemat
extens
screen
respiratori
virus
nation
level
implement
purpos
rsv
infect
observ
contrast
usual
epidemiolog
character
last
four
past
year
start
epidem
week
confirm
laboratori
french
inv
rsv
epidem
delay
lower
impact
compar
previou
winter
season
delay
reduc
rsv
spread
may
due
viral
interfer
rsv
influenza
anoth
possibl
explan
better
prevent
behaviour
respiratori
infect
recommend
nation
campaign
includ
recommend
hand
wash
sneez
use
mask
influenza
infect
mainli
detect
patient
year
old
case
found
patient
older
result
corrobor
previou
data
suggest
past
season
infect
vaccin
may
give
partial
cross
protect
previous
shown
neutral
titer
pandem
viru
correl
significantli
neutral
titer
season
viru
pandem
influenza
viru
neutral
titer
significantli
higher
subject
recent
inocul
season
trival
influenza
vaccin
viral
coinfect
predominantli
seen
paediatr
patient
previous
describ
influenza
noninfluenza
case
similar
rate
evid
pronounc
respiratori
impact
seen
patient
result
show
lack
specif
clinic
sign
associ
proven
infect
clinic
characterist
differ
influenza
infect
viral
infect
particular
proport
patient
fever
higher
posit
patient
addit
patient
without
evid
respiratori
viral
infect
differ
symptom
patient
may
infect
viru
includ
multiplex
assay
human
bocaviru
coronaviru
seen
late
time
viral
shed
clear
howev
determin
specif
symptom
influenza
would
requir
assess
also
distribut
respiratori
pathogen
respiratori
virus
relat
symptom
patient
present
emerg
depart
sl
tr
respiratori
syndrom
test
addit
despit
underli
condit
associ
complic
previous
observ
season
influenza
ill
caus
viru
acut
selflimit
higher
proport
non
influenza
virus
report
ili
thu
like
consequ
frequent
visit
doctor
respiratori
tract
infect
usual
observ
fear
flu
pandem
gener
lack
differ
symptom
particular
context
pandem
therefor
consid
caution
rule
signific
differ
may
aris
futur
influenza
epidem
influenza
virus
data
confirm
may
virtual
imposs
recogn
symptom
herald
infect
virolog
data
help
along
clinic
report
monitor
influenza
epidem
molecular
multiplex
detect
recent
emerg
potent
diagnost
tool
determin
acut
respiratori
infect
aetiolog
data
show
sensit
molecular
multiplex
detect
respiratori
virus
feasibl
effici
detect
viru
involv
acut
respiratori
infect
provid
insight
epidem
profil
result
confirm
perform
assay
detect
respiratori
virus
gener
popul
recent
shown
transplant
patient
ili
confirm
infect
detect
cdc
refer
assay
abl
identifi
two
addit
case
suggest
high
sensit
multiplex
assay
detect
influenza
infect
conclus
result
highlight
success
mix
outbreak
respiratori
viral
infect
may
affect
influenza
epidemiolog
lead
misinterpret
earli
develop
flu
epidem
rapid
diagnost
screen
larg
panel
respiratori
pathogen
may
critic
defin
survey
epidem
situat
provid
critic
inform
patient
manag
